Manipal Health Enterprises Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Manipal Health Enterprises Ltd is ₹ 668.45 as of 30 Oct 15:30 . The P/E Ratio of Manipal Health Enterprises Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Manipal Health Enterprises Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Manipal Health Enterprises Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 3165 crore. This represent the decline of -100% The revenue of Syngene International Ltd for the Sep '26 is ₹ 860.7 crore as compare to the Jun '26 revenue of ₹ 761.3 crore. This represent the growth of 13.06% The ebitda of Manipal Health Enterprises Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 795.7 crore. This represent the decline of -100% The ebitda of Syngene International Ltd for the Sep '26 is ₹ 168.7 crore as compare to the Jun '26 ebitda of ₹ 102.6 crore. This represent the growth of 64.42% The net profit of Manipal Health Enterprises Ltd changed from ₹ 254.04 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 32.2 crore over 10 quarters. This represents a CAGR of -28.96% The Dividend Payout of Manipal Health Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Manipal Health Enterprises Ltd

Manipal Health Enterprises Limited was originally incorporated in Bengaluru, Karnataka as Manipal Health Enterprises Private Limited' as a private limited company dated February 15, 2010, issued by the RoC. Subsequently, Company was converted to a public limited company and the name was changed to Manipal Health Enterprises Limited and a fresh certificate of incorporation dated December 24, 2025 was issued by the Central Processing Centre.
The Company is engaged in the business of running/managing hospitals, and providing healthcare services.
It operates through various Hospitals/clinics providing Healthcare services and diagnostic centres, in India. The Company commenced its operations at Bengaluru, Karnataka, Near Manipal Hospital Old Airport Road in year 1991.
In 1993, it expanded presence in hospitals in Bengaluru and further to Goa in 1994, commenced operations in Mangalore at KMC Hospital in 1997.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5,778scientists and its state-of-the-art facilities, spread over 3 million sq. ft.
The Company operate into 4 business divisions comprising of Discovery Services, Translational & Clinical Research, Dedicated Centers, and Contract Development and Manufacturing Services. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Manipal Health Enterprises Ltd and Syngene International Ltd

Which company has a larger market capitalization, Manipal Health Enterprises Ltd or Syngene International Ltd?

Market cap of Manipal Health Enterprises Ltd is 87,926 Cr while Market cap of Syngene International Ltd is 16,251 Cr

What are the key factors driving the stock performance of Manipal Health Enterprises Ltd and Syngene International Ltd?

The stock performance of Manipal Health Enterprises Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Manipal Health Enterprises Ltd and Syngene International Ltd?

As of October 31, 2026, the Manipal Health Enterprises Ltd stock price is INR ₹668.45. On the other hand, Syngene International Ltd stock price is INR ₹402.6.

How do dividend payouts of Manipal Health Enterprises Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Manipal Health Enterprises Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.